NCT02723994 2026-03-11A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic LeukemiaIncyte CorporationPhase 2 Completed171 enrolled
NCT00400946 2026-02-1305-001: Treatment of Acute Lymphoblastic Leukemia in ChildrenDana-Farber Cancer InstitutePhase 3 Completed800 enrolled 22 charts